Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HO2T
|
||||
Former ID |
DCL000479
|
||||
Drug Name |
AZD7325
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H19FN4O2
|
||||
InChI |
InChI=1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25)
|
||||
InChIKey |
KYDURMHFWXCKMW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glutamate receptor AMPA subtype | Target Info | Agonist | [550288] | |
References | |||||
Ref 522519 | ClinicalTrials.gov (NCT00807937) Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325. U.S. National Institutes of Health. | ||||
Ref 542687 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7712). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.